CRISPR gene editing breakthrough eliminates 50% of head, neck tumors
Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, ...
The Motley Fool1y
The Best CRISPR Companies to Invest In
CRISPR (clustered regularly interspaced short palindromic repeats) genome editing has been hyped for years. But the promise of CRISPR technology ... clinical trial results. But Editas still ...
pharmaphorum6d
China to begin first in-human CRISPR trial next month
The CRISPR-led gene-editing revolution is set to begin next month in its first ever trial in humans ... than current PD-1–targeted drugs as the technology directly knocks-out the gene ...
pharmaphorum3d
First patient dosed in trial of Allergan/Editas’ CRISPR blindness drug
A first patient has been treated in a trial of an Allergan and Editas drug based on CRISPR/Cas9, a technology that allows genes to be manipulated inside the body. The two companies claim AGN ...
technologynetworks14d
New CRISPR Technology Enhances Genetic Interaction Research in Disease
Yale scientists have developed a CRISPR technology that can assess genetic interactions on a host of immunological responses to multiple diseases, including cancer. Now, however, Yale scientists have ...